Clinical Trial Update: Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating pembrolizumab in combination with bevacizumab and oral cyclophosphamide for high-grade ovarian cancer with surgically docum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ovarian Cancer | Phase 2 | Status: RECRUITING